Cited by 346Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

Western diet as a trigger of Alzheimer’s disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration

Open access
Więckowska-Gacek, Angelika, Mietelska-Porowska, Anna, Wydrych, Małgorzata, Wojda, Urszula·2021·Ageing Research Reviews

Abstract

An excess of saturated fatty acids and simple sugars in the diet is a known environmental risk factor of Alzheimer's disease (AD) but the holistic view of the interacting processes through which such diet may contribute to AD pathogenesis is missing. We addressed this need through extensive analysis of published studies investigating the effects of western diet (WD) on AD development in humans and laboratory animals. We reviewed WD-induced systemic alterations comprising metabolic changes, induction of obesity and adipose tissue inflammation, gut microbiota dysbiosis and acceleration of systemic low-grade inflammation. Next we provide an overview of the evidence demonstrating that WD-associated systemic alterations drive impairment of the blood-brain barrier (BBB) and development of neuroinflammation paralleled by accumulation of toxic amyloid. Later these changes are followed by dysfunction of synaptic transmission, neurodegeneration and finally memory and cognitive impairment. We conclude that WD can trigger AD by acceleration of inflammaging, and that BBB impairment induced by metabolic and systemic inflammation play the central role in this process. Moreover, the concurrence of neuroinflammation and Aβ dyshomeostasis, which by reciprocal interactions drive the vicious cycle of neurodegeneration, contradicts Aβ as the primary trigger of AD. Given that in 2019 the World Health Organization recommended focusing on modifiable risk factors in AD prevention, this overview of the sequential, complex pathomechanisms initiated by WD, which can lead from peripheral disturbances to neurodegeneration, can support future prevention strategies.

Integrity signals

Registry

Crossref · 10.1016/j.arr.2021.101397

Cites

324 of 324 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased intestinal permeability facilitates the translocation of bacteria and their byproducts into the mucosa and bloodstream, leading to aberrant activation of intestinal and circulating immune and inflammatory cells, resulting in systemic inflammation, neuroinflammation, and neurodegeneration.

    “the increased intestinal permeability facilitates the translocation of bacteria and their byproducts into the mucosa and bloodstream. This leads to aberrant activation of the intestinal and circulating immune and inflammatory cells, resulting in systemic inflammation, neuroinflammation, and neurodegeneration.”
  • Systemic inflammation may disrupt the BBB, allowing pro-inflammatory molecules to enter the CNS.

    “According to previous studies, systemic inflammation may disrupt the BBB, allowing pro-inflammatory molecules (such as cytokines and LPS) to enter the CNS [60,61,62].”

Cites

1 retracted

Flagged first, then by citations

4 of the 328 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Więckowska-Gacek, A., Mietelska-Porowska, A., Wydrych, M., & Wojda, U.
Affiliations
Instytut Biologii Doświadczalnej im. Marcelego Nenckiego (PL)
Venue
Ageing Research Reviews
Publisher
Elsevier BV
Published
2021-09
Volume
70
Pages
101397
ISSN
1568-1637 (ISSN-L)
OpenAlex
W3174384278
Cited by
343
References
328
Citations by year
2026: 53 · 2025: 75 · 2024: 92 · 2023: 71 · 2022: 43 · 2021: 9
FWCI
7.27
Type
journal article
Language
en
Open access
Locations
  • Ageing Research Reviews (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Narodowe Centrum Nauki (UMO-2014/15/D/NZ4/04361, UMO-2018/29/N/NZ7/01724)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Western diet, Alzheimer's disease, metabolic syndrome, systemic inflammation, neuroinflammation, neurodegeneration, blood-brain barrier, amyloid-beta, inflammaging, gut dysbiosis, obesity, adipose tissue inflammation, synaptic dysfunction, memory impairment, cognitive impairment, dietary saturated fatty acids, sugar consumption, modifiable risk factors
MeSH terms
Alzheimer Disease, Animals, Humans, Inflammation, Metabolic Syndrome, Cognitive Dysfunction, Diet, Western

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review